## TXN: Texas Instruments Incorporated - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 5.5% in lower entry zone (4.0-10.0%), top quartile (86th pct) cross-sectional ranking. Caution: MRS_5 (-1.1%) diverging from MRS_20, watch for reversal. Outperforming sector by 4.2%. Caution: momentum weakening (-4.6% MRS).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($169.74)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Arrowstreet Capital Limited Partnership Purchases New Shares in Texas Instruments Incorporated $TXN**
- Source: MarketBeat | 20251207T120925 | Neutral | Relevance: 99%
-  Arrowstreet Capital Limited Partnership bought 129,638 shares of Texas Instruments, valued at approximately $26.9 million, initiating a new position in the semiconductor company. Texas Instruments recently reported EPS matching estimates and raised its quarterly dividend, though analyst views and price targets are mixed. Institutional investors own a significant portion of the stock, while some insiders have sold shares.

**2. WINTON GROUP Ltd Increases Stock Holdings in Texas Instruments Incorporated $TXN**
- Source: MarketBeat | 20251209T140847 | Somewhat-Bullish | Relevance: 99%
-  WINTON GROUP Ltd significantly increased its stake in Texas Instruments Incorporated (NASDAQ:TXN) by 867.2% in Q2, bringing its total holdings to 19,374 shares valued at approximately $4.02 million. This move is part of broader institutional interest, with other major firms like Norges Bank and Vanguard Group also accumulating substantial shares. Texas Instruments recently raised its quarterly dividend to $1.42, despite a high dividend payout ratio, and reported Q3 EPS of $1.48, meeting analyst expectations.

**3. Natixis Sells 114,096 Shares of Texas Instruments Incorporated $TXN**
- Source: MarketBeat | 20251208T130848 | Neutral | Relevance: 99%
-  Natixis reduced its stake in Texas Instruments Incorporated by 38.2% in the second quarter, selling 114,096 shares and now holding 184,841 shares valued at $38.38 million. Texas Instruments reported in-line EPS and raised its quarterly dividend, while several analysts lowered price targets and the consensus rating is "Hold". Other institutional investors also adjusted their positions in the semiconductor company.

**4. Texas Instruments Incorporated $TXN Shares Purchased by Winslow Capital Management LLC**
- Source: MarketBeat | 20251208T125945 | Neutral | Relevance: 98%
-  Winslow Capital Management LLC increased its stake in Texas Instruments (NASDAQ:TXN) by 11.8% during the second quarter, making it their 29th largest holding. The semiconductor company recently reported strong earnings, beating revenue estimates and raising its quarterly dividend. Analysts maintain a "Hold" consensus rating for TXN, with varied price targets.

**5. State Street Corp Has $9 Billion Holdings in Texas Instruments Incorporated $TXN**
- Source: MarketBeat | 20251209T131806 | Neutral | Relevance: 98%
- State Street Corp significantly increased its stake in Texas Instruments, now holding 4.77% ownership valued at nearly $9 billion. Despite this, several analysts have trimmed price targets, resulting in a consensus "Hold" rating for TXN with a target of $191.67. Texas Instruments also raised its quarterly dividend, offering a 3.1% yield, though its payout ratio is currently high at 103.8%.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 4 ($0.58M) |
| Sells | 4 ($0.52M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 10.6% (+1.1%)
- Blackrock Inc.: 8.5% (+0.1%)
- JPMORGAN CHASE & CO: 6.0% (+80.5%)
- State Street Corpora: 4.8% (+0.5%)
- Charles Schwab Inves: 2.5% (+3.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.56 elevated, pricing in significant growth expectations. Forward P/E 29.2x stretched relative to 12% growth. Quality metrics strong (ROE 30%, ROA 11%, margin 29%). Balance sheet: strong liquidity (4.5x). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $163.2B |
| Beta | 0.99 |
| 52W Range | $139.95 - $221.69 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.56 |
| Forward P/E | 29.2 |
| Current P/E | 32.8 |
| YoY Growth | 12.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 10.1% to 5.5% (-4.6% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 86th percentile. MRS_5 (-1.1%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 7.8% shows strong absolute momentum above own 20MA. Outperforming sector by 4.2pp, stock-specific strength. Below SMA200 (0.98x), long-term trend not supportive. MACD histogram positive (2.63), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.52% (CS: 87) | Strong |
| RSI_14 | 63.4 | Neutral |
| MACD Histogram | 2.63 | Bullish |
| vs SMA20 | 1.077x | Above |
| vs SMA50 | 1.058x | Above |
| vs SMA200 | 0.985x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $179.52
- **Stop Loss:** $169.74 (5.4% risk)
- **Target:** $194.19 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 122
- **Position Value:** $21,901.44
- **Portfolio %:** 21.90%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-01-20 (Est: $1.31)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.49 | $1.48 | -0.4% |
| 2025Q2 | $1.33 | $1.41 | +5.8% |
| 2025Q1 | $1.06 | $1.28 | +20.2% |
| 2024Q4 | $1.20 | $1.30 | +8.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*